drugset / Trial / NCT00421460

The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction

NCT00421460

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the response of a treatment with testosterone undecanoate and determine the levels of total and free testosterone in hypogonadal patients with erectile dysfunction.

Timeline

Start
2007-01
Primary completion
2011-01
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 1000 mg Intramuscular